TipRanks
Bristol-Myers Squibb (MX:BMY)
:BMY
Mexico Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BMY) Ratios

0 Followers

Bristol-Myers Squibb Ratios

MX:BMY's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, MX:BMY's free cash flow was decreased by $ and operating cash flow was $0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 -12.24 1.26 1.25 1.43 1.25
Quick Ratio
 -12.24 1.14 1.15 1.31 1.14
Cash Ratio
 -9.31 0.44 0.44 0.51 0.42
Solvency Ratio
 -0.27 0.15 <0.01 0.27 0.25
Operating Cash Flow Ratio
 -10.36 0.60 0.64 0.62 0.60
Short-Term Operating Cash Flow Coverage
 -10.36 6.26 7.42 4.44 3.06
Net Current Asset Value
$ 55.46B$ -42.14B$ -46.44B$ -33.90B$ -38.43B
Leverage Ratios
Debt-to-Assets Ratio
 -3.41 0.52 0.55 0.44 0.42
Debt-to-Equity Ratio
 -0.77 2.55 3.13 1.41 1.31
Debt-to-Capital Ratio
 -3.41 0.72 0.76 0.58 0.57
Long-Term Debt-to-Capital Ratio
 -3.08 0.70 0.74 0.55 0.53
Financial Leverage Ratio
 0.23 4.87 5.67 3.23 3.12
Debt Service Coverage Ratio
 16.20 3.12 0.65 4.43 3.25
Interest Coverage Ratio
 6.17 7.26 4.96 7.27 7.53
Debt to Market Cap
 -0.34 0.41 0.43 0.37 0.26
Interest Debt Per Share
 -20.18 24.02 26.22 20.60 19.69
Net Debt to EBITDA
 -4.30 2.42 12.90 1.55 1.64
Profitability Margins
Gross Profit Margin
51.41%71.08%56.80%56.34%57.39%
EBIT Margin
20.08%23.28%-13.32%21.34%19.38%
EBITDA Margin
24.41%31.60%6.56%43.03%41.64%
Operating Profit Margin
20.39%28.48%20.00%18.82%20.08%
Pretax Profit Margin
22.65%19.35%-17.35%18.75%16.71%
Net Profit Margin
18.47%14.64%-18.53%17.83%13.71%
Continuous Operations Profit Margin
18.47%14.64%-18.49%17.86%13.75%
Net Income Per EBT
81.57%75.62%106.79%95.08%82.03%
EBT Per EBIT
111.07%67.97%-86.76%99.62%83.19%
Return on Assets (ROA)
73.47%7.83%-9.66%8.43%6.53%
Return on Equity (ROE)
31.79%38.19%-54.78%27.27%20.37%
Return on Capital Employed (ROCE)
74.97%20.60%14.03%11.62%12.37%
Return on Invested Capital (ROIC)
11.63%15.03%13.59%10.59%9.61%
Return on Tangible Assets
-35.43%14.34%-18.94%17.26%16.09%
Earnings Yield
7.37%6.41%-7.80%7.56%4.13%
Efficiency Ratios
Receivables Turnover
 0.00 3.32 3.35 2.95 3.31
Payables Turnover
 0.00 3.90 5.79 6.03 6.47
Inventory Turnover
 0.00 5.18 8.16 7.38 8.41
Fixed Asset Turnover
 0.00 5.28 5.78 5.60 6.18
Asset Turnover
 3.98 0.54 0.52 0.47 0.48
Working Capital Turnover Ratio
 4.25 8.05 6.23 6.04 5.50
Cash Conversion Cycle
 0.00 86.82 90.72 112.70 97.20
Days of Sales Outstanding
 0.00 110.00 109.00 123.79 110.21
Days of Inventory Outstanding
 0.00 70.45 44.72 49.45 43.41
Days of Payables Outstanding
 0.00 93.63 63.00 60.54 56.41
Operating Cycle
 0.00 180.46 153.73 173.24 153.61
Cash Flow Ratios
Operating Cash Flow Per Share
 5.21 6.94 7.49 6.70 6.13
Free Cash Flow Per Share
 4.55 6.29 6.88 6.11 5.61
CapEx Per Share
 0.67 0.64 0.62 0.58 0.52
Free Cash Flow to Operating Cash Flow
 0.87 0.91 0.92 0.91 0.91
Dividend Paid and CapEx Coverage Ratio
 1.64 2.23 2.49 2.33 2.27
Capital Expenditure Coverage Ratio
 7.80 10.80 12.17 11.46 11.69
Operating Cash Flow Coverage Ratio
 -0.25 0.30 0.30 0.33 0.32
Operating Cash Flow to Sales Ratio
 0.21 0.29 0.31 0.31 0.28
Free Cash Flow Yield
7.40%11.67%12.16%11.92%7.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.58 15.59 -12.81 13.23 24.22
Price-to-Sales (P/S) Ratio
 2.51 2.28 2.37 2.36 3.32
Price-to-Book (P/B) Ratio
 2.26 5.96 7.02 3.61 4.93
Price-to-Free Cash Flow (P/FCF) Ratio
 13.50 8.57 8.22 8.39 12.83
Price-to-Operating Cash Flow Ratio
 11.77 7.78 7.55 7.66 11.73
Price-to-Earnings Growth (PEG) Ratio
 0.26 -0.09 0.06 0.43 -4.24
Enterprise Value Multiple
 5.97 9.65 49.08 7.03 9.62
Enterprise Value
 72.95B 147.02B 155.50B 136.16B 184.85B
EV to EBITDA
 5.97 9.65 49.08 7.03 9.62
EV to Sales
 1.46 3.05 3.22 3.03 4.00
EV to Free Cash Flow
 7.86 11.45 11.15 10.76 15.47
EV to Operating Cash Flow
 6.85 10.39 10.24 9.82 14.15
Tangible Book Value Per Share
 8.22 -10.95 -14.29 -9.26 -12.39
Shareholders’ Equity Per Share
 27.15 9.05 8.06 14.22 14.58
Tax and Other Ratios
Effective Tax Rate
 0.18 0.24 -0.07 0.05 0.18
Revenue Per Share
 24.49 23.61 23.83 21.75 21.67
Net Income Per Share
 4.52 3.46 -4.41 3.88 2.97
Tax Burden
 0.82 0.76 1.07 0.95 0.82
Interest Burden
 1.13 0.83 1.30 0.88 0.86
Research & Development to Revenue
 0.21 0.21 0.20 0.20 0.20
SG&A to Revenue
 0.15 0.15 0.16 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.01 0.01 0.01 <0.01
Income Quality
 1.15 2.01 -1.70 1.72 2.06
Currency in USD